Immunic AG | WebDisclosure

PRESS RELEASE

published on 04/30/2025 at 13:30, 1 year 5 months ago

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial
Immunic announces positive results from Phase 2 CALLIPER trial showing 30% reduced risk of disability worsening in Primary Progressive Multiple Sclerosis patients with vidofludimus calcium. Webcast scheduled for April 30

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 2 CALLIPER Trial
BRIEF

published on 04/10/2025 at 19:05, 1 year 6 months ago

Immunic Closes $5.1 Million Direct Offering Led by Aberdeen Investments

Biotechnology Chronic Diseases Direct Offering Aberdeen Investments Immunic Funding
BRIEF

published on 04/10/2025 at 19:05, 1 year 6 months ago

Immunic clôture une offre directe de 5,1 millions de dollars menée par Aberdeen Investments

Biotechnologie Maladies Chroniques Offre Directe Investissements Aberdeen Financement Immunitaire
PRESS RELEASE

published on 04/10/2025 at 19:00, 1 year 6 months ago

Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. closes $5.1 million direct offering led by Aberdeen Investments to fund clinical trials and operations for autoimmune diseases. Issued via PRNewswire

Clinical Trials Immunic Inc. Autoimmune Diseases Direct Offering Aberdeen Investments
BRIEF

published on 04/09/2025 at 14:15, 1 year 6 months ago

Immunic, Inc. Announces $5.1 Million Direct Offering Guided by Aberdeen Investments

Biotechnology Nasdaq Investment Immunic, Inc. Direct Offering
BRIEF

published on 04/09/2025 at 14:15, 1 year 6 months ago

Immunic, Inc. annonce une offre directe de 5,1 millions de dollars, pilotée par Aberdeen Investments

Investissement Biotechnologie Nasdaq Immunic, Inc. Offre Directe
PRESS RELEASE

published on 04/09/2025 at 14:10, 1 year 6 months ago

Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. announces pricing of $5.1 million registered direct offering led by Aberdeen Investments for clinical pipeline of therapies. Funds to be used for clinical trials and operations

Registered Direct Offering Immunic Inc. Clinical Pipeline Thérapies Aberdeen Investments
BRIEF

published on 04/01/2025 at 12:35, 1 year 6 months ago

Immunic, Inc. Announces Participation in Key April Conferences

Biotechnology Conférences Immunic Inc. Vidofludimus Calcium Neuroprotection
BRIEF

published on 04/01/2025 at 12:35, 1 year 6 months ago

Immunic, Inc. annonce sa participation aux principales conférences d'avril

Biotechnologie Conférences Immunic Inc. Neuroprotection Vidofludimus Calcique
PRESS RELEASE

published on 04/01/2025 at 12:30, 1 year 6 months ago

Immunic, Inc. to Participate in Scientific and Industry Conferences in April
Immunic, Inc. to participate in scientific and industry conferences in April, including American Academy of Neurology 2025 Annual Meeting and German Biotech Days 2025

Immunic Inc. Industry Conferences Scientific Conferences American Academy Of Neurology German Biotech Days

Published on 10/10/2026 at 04:45, 17 hours 51 minutes ago

Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 20 hours 33 minutes ago

BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 20 hours 36 minutes ago

Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 23 hours 36 minutes ago

Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 1 day ago

Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call

View all ACCESSWIRE

Published on 10/10/2026 at 16:35, 6 hours 1 minute ago

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 6 hours 6 minutes ago

ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 12 hours 31 minutes ago

ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 1 day 1 hour ago

Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 1 day 1 hour ago

EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected

View all EQS

Published on 10/09/2026 at 19:27, 1 day 3 hours ago

Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 1 day 3 hours ago

Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 18:01, 1 day 4 hours ago

Titre de mon communiqué
Published on 10/09/2026 at 18:01, 1 day 4 hours ago

Title of my press release
Published on 10/09/2026 at 17:45, 1 day 4 hours ago

Déclaration des droits de vote à fin septembre 2026

View all LES ECHOS COMFI WIRE

News